Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 11/2018

01-11-2018 | Classics in Abdominal Radiology

Tree-in-bud sign

Authors: Quentin Minault, Anne Karol, Francis Veillon, Aina Venkatasamy

Published in: Abdominal Radiology | Issue 11/2018

Login to get access

Excerpt

The tree-in-bud pattern represents bronchiolar luminal impaction with mucus, pus or fluid, which demarcates the normally invisible branching course of the distal peripheral pathways, thus resembling a tree branch studded with buds on High-Resolution CT of the lungs (Figs. 1, 2) [1]. This sign corresponds to small (2–4 mm) and peripheral (close to the pleural surface) well-defined small nodules of soft-tissue attenuation which are connected to linear branching opacities with more than one contiguous branching site [1]. It is a pattern of centrolobular nodules characterized by impaction of the terminal bronchioles. …
Literature
1.
Attaya M, Attaya E, Islam E (2014) Tree-in-bud. Southwest Respir Crit Care Chron 2(8):42–43CrossRef
2.
Im JG, Itoh H, Shim YS, et al. (1993) Pulmonary tuberculosis: CT findings–early active disease and sequential change with antituberculous therapy. Radiology 186(3):653–660CrossRef
3.
Collins J, Blankenbaker D, Stern EJ (1998) CT patterns of bronchiolar disease: what is “tree-in-bud”? AJR Am J Roentgenol 171(2):365–370CrossRef
4.
Rossi SE, Franquet T, Volpacchio M, Giménez A, Aguilar G (2005) Tree-in-bud pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics 25(3):789–801CrossRef
Metadata
Title
Tree-in-bud sign
Authors
Quentin Minault
Anne Karol
Francis Veillon
Aina Venkatasamy
Publication date
01-11-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1562-8

Other articles of this Issue 11/2018

Abdominal Radiology 11/2018 Go to the issue

OriginalPaper

Prevalence of renal cysts and association with risk factors in a general population: an MRI-based study

OriginalPaper

Hepatopulmonary shunting on Tc99m-MAA liver mapping: correlation with dynamic cross-sectional imaging and description of different shunting patterns

OriginalPaper

Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography

Pictorial essay

Mucinous appendiceal neoplasms: pathologic classification, clinical implications, imaging spectrum and mimics

OriginalPaper

Role of MRI and added value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of local recurrence from rectal cancer

Classics in Abdominal Radiology

Pseudocirrhosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits